XLO
Xilio Therapeutics
$7.77
−$0.24 (−3%)Oct 29, 2026
Key metrics
The numbers that frame XLO today
- Market cap
- $51.13M
- Gross margin
- 100%
- ROIC
- 95.5%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $6.47
- 52wk High
- $12.59
Growth
Revenue and earnings trend for XLO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about XLO
Is Xilio Therapeutics a good buy?
Hold. Xilio Therapeutics has weak quality and mixed momentum. The setup is mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together.
What is the market capitalization of XLO?
Xilio Therapeutics's market capitalization is $51.13M.
What is the 52-week high for XLO stock?
The 52-week high for Xilio Therapeutics is $12.59. The current close of $7.77 is 38.3% below that high.
What is the 52-week low for XLO stock?
The 52-week low for Xilio Therapeutics is $6.47. The current close of $7.77 is 20.2% above that low.
Does XLO stock pay dividends?
Xilio Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for XLO?
Xilio Therapeutics's Debt / Equity ratio is 0.09.